©2019 by XII International Symposium on Vasoactive Peptides

DEGREES, PREVIOUS AND PRESENT POSITIONS 1978: Ph.D. in Neurobiology Faculty of Sciences, University Pierre and Marie Curie, Paris VI 1987-1990: Permanent Researcher position (CR1) at the INSERM Institute, INSERM U109 of Neurobiology and Molecular Pharmacology - INSERM - 75014 PARIS 1991-1993: Permanent Researcher position (CR1) at the INSERM Institute, INSERM U36 at College de France - Chair of Experimental Medicine - 75005 PARIS 1994: Accreditation to supervise research 1994-2003: Research Director DR2 INSERM at the College de France, INSERM U36 - 75005 PARIS 2003 -: Research Director DR1 INSERM, Director of the INSERM Research Unit U691 entitled: «Central Neuropeptides and the Regulation of the Body Fluid Homeostasis and Cardiovascular Functions», at the College de France, now integrated in the CIRB-Collège de France-INSERM U1050- CNRS7241 2017: Research Director INSERM (outstanding class) SCIENTIFIC MEMBERSHIP Vice-President of the French Society of Experimental Neuroendocrinology Member of the French Society of Neurosciences and of Biology Member of the French Society of Arterial Hypertension Member of the French Society of Cardiology Member of the Society for Neuroscience – USA President of the Scientific Committee of the Foundation for Cardio-Vascular Research, Institut de France EDITORIAL ACTIVITY Since 1999: Member of the Editorial board of the Journal NEUROENDOCRINOLOGY 2002-2013: Editor-Reviewer of the JOURNAL OF NEUROCHEMISTRY PRIZE AND DISTINCTIONS 1981: Prize of the Medical Research Foundation - Neurobiology 2002: Prize of the French Academy of Sciences (Pierre Desnuelle) - Molecular and Cellular Biology 2006: Recipient of the Jacques Benoît Lecture, International Congress of Neuroendocrinology Pittsburgh, USA 2009: Prize of the Foundation of the Société Générale Asset Management for Therapeutic Innovation 2012: Danièle Hermann Prize awarded by the Foundation for Cardio-Vascular Research - Institut de France 2012: Notification and award for outstanding scientific activity from the INSERM Research Institute 2013: Named Knight of the French Honor Legion (Ministry of Health) 2014 : Galien Price France 2014 (Section Research) CONTRACTS OF COLLABORATION 2005-2008: 2 Contrats d’Initiation à la Recherche Clinique APHP 2005-2008: ANR(National Agency for Research) Cardiovascular/Obesiy/Diabetes 2006-2007: ANR Emergence and Maturation 2007-2009: Quantum Genomics Company 2009-2012: ANR Physics, Chemistry and Biology 2009-2012: ANR BiotecS 2013-2014: Foundation for Arterial Hypertension Research 2014-2016: ANR Biomedical Innovation in public-private Research Partnership (RPIB) 2015-2017: ANR Joint laboratories public/private (LabCom) 2015 - 2017: Contract Proof of Concept "CoPoC" INSERM Transfert "Apelinatremia" 2017-2021 ANR generic “FLUOROPEP” 2017-2020: Contract of collaboration with Quantum Genomics Company, 2018-2020: Contract Foundation for Medical Research"Cardiovascular Pathologies" BEST PUBLICATIONS - Pollard H, Llorens-Cortes C. Schwartz JC. Nature, 1977; 268: 745-747. - Llorens-Cortes C, Martres MP, Baudry M, Schwartz JC. Nature, 1978; 274: 603-605. - Roques BP, Fournie-Zaluski MC et al, Llorens-Cortes C, Schwartz JC. Nature, 1980; 288: 286-288. - Llorens-Cortes C, Gros C, Schwartz JC. Proc. Natl. Acad. Sci. (PNAS), 1986; 83: 6226-6230. - Zini S, Fournie-Zaluski MC et al, Roques BP, Corvol P, Llorens-Cortes C. PNAS, 1996; 93:11968-11973. - Reaux A, Fournie-Zaluski et al, Roques BP, Corvol P, Llorens-Cortes C. PNAS, 1999; 96(23):13415-20. - Fournie-Zaluski M-C, Fassot C et al, Corvol P, Roques BP, Llorens-Cortes C. PNAS, 2004;101:7775-80. - De Mota N, Reaux-Le Goazigo A et al, Llorens-Cortes C. PNAS, 2004;101(28):10464-9. - Chartrel N, Alvear-Perez R et al, Llorens-Cortes C. Science, 2007; 315(5813):766 - Azizi M, Iturrioz X, et al, Llorens-Cortes C. J. Am. Soc. Nephrol., 2008; 19(5):1015-24. - Bodineau L, Frugiere A, Marc Y, et al , Roques B, Llorens-Cortes C. Hypertension, 2008; 51:1318-1325 - Iturrioz X, Alvear-Perez R, De Mota N et al., Llorens-Cortes C. FASEB J., 2010; 24(5):1506-17. - Marc Y & Llorens-Cortes C. Prog Neurobiol., 2011; 95(2):89-103 - Chartrel N, Alonzeau J, et al., Llorens-Cortes C. Front Neuroendocrinol., 2011;301(5):E955-66. - Marc Y, Ji G, Balavoine F, Michaud A, Roques B, Llorens-Cortes C. Hypertension, 2012; 60(2):411-8. - Huang B, Ahmad M, White R, Marc Y, Llorens-Cortes C, Leenen F. Cardiovasc Res., 2013; 97(3):424-31. - Balavoine F, Azizi M , Bergerot D, et al., Llorens-Cortes C. Clin Pharmacokinet. 2014; 53, 385–395 - Gerbier R, Leroux V, et al., Llorens-Cortes C, Iturrioz X. FASEB J., 2015; 29, 314–322. - Gerbier R, Alvear-Perez R, Margathe J-F, et al., Llorens-Cortes C. FASEB J. 2017 ; 31(2), 687-700. - Boitard SE, Marc Y, et al., Llorens-Cortes C. J. Mol. Cell. Cardiol., 2018 S0022-2828(18)30783-1. - Keck M, De Almeida H, et al., Balavoine F, Roques BP, Llorens-Cortes C. Hypertension, 2019; 73:1300-7. - INVITED CONFERENCES 1999: Gordon Research Conference on Angiotensin, Oxford, UK 2003: International Protease Symposium General Meeting, Nagoya, Japan 2004: Gordon Research Conference on Angiotensin, Ventura, USA 2005: American Physiological Society Conference, Steamboat Springs, USA 2009: XVIIIth Meeting of the Inter-American Society of Hypertension, Belo Horizonte, Brazil 2010: 18th International Symposium on Regulatory Peptides, Ireland -Zing Cardiovascular Conference, Mexico 2011: 1st Brazilian International Symposium on Integrative Neuroendocrinology, Dourado, Brazil 2012: Gordon Research Conference on Angiotensin, Ventura, USA - 3rd Kinin International Symposium, Paris 3rd Kinin International Symposium, Paris 2013: IX International Symposium on Vasoactive Peptides, Minas Geras, Brésil Colloque de la Socièté de Neuroendocrinologie, Fès, Maroc 2014: Joint Meeting of the Federation of European Physiological Societies, Budapest, Hongrie XVIIIth Meeting of the European Council for Cardiovascular Research, Poiano, Italy. 4ème Journée Scientifique du Réseau Québecois: Recherche sur les Médicaments, Montréal, Canada 2015: 23ème Meeting of the Quebec Society of Hypertension, Montreal, Canada. Plenary Lecture. X International Symposium on Vasoactive Peptides, Minas Gerais, Brésil. 5ème Colloque Annuel du Labex Lermit - Cachan, France. Conférence Plénière 2016: International Regulatory Peptide Society Meeting, Rouen, France American Heart Association - New Orleans, USA 26th European Meeting on Hypertension and Cardiovascular Protection, Paris, France 17th Congress of the European Neuroendocrine Association, Milan, Italie 2017: International Society for Autonomic Neuroscience (ISAN) - Nagoya, Japan 21th Annual Meeting of the European Council for Cardiovascular Research (ECCR) - Lake Garda, Italy XI International Symposium on Vasoactive Peptides - Belo Horizonte, Brazil 2018: Gordon Research Conference on Angiotensin, Ventura, USA 54th International Conference on Medicinal Chemistry, Strasbourg, France. Plenary Lecture. 22nd International Symposium on Regulatory Peptides, Acapulco, Mexique 206 PUBLICATIONS: 130 original articles + 35 reviews in Web of Science + 41 reviews of speciality and book chapters . Research in Web of Science: (Llorens* C and Schwartz JC or Llorens-Cortes C or LlorensCortes C or VanAmsterdam JGC and LlorensCortes C or Cortes C and Beaudet A). 9 Patents; 15 Directions of PhD thesis. Facteur H: 58 - see Google Scholar Llorens-Cortès

Catarine LLORENS-CORTES